{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:04:56Z","timestamp":1792087496167,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No.81602059"],"award-info":[{"award-number":["No.81602059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Previous studies on the molecular classification of cholangiocarcinoma (CCA) focused on certain anatomical sites, and disregarded tissue contamination biases in transcriptomic profiles. We aim to provide universal molecular classification scheme and prognostic biomarker of CCAs across anatomical locations. Comprehensive bioinformatics analysis is performed on transcriptomic data from 438 CCA cases across various anatomical locations. After excluding CCA tumors showing normal tissue expression patterns, we identify two universal molecular subtypes across anatomical subtypes, explore the molecular, clinical, and microenvironmental features of each class. Subsequently, a 30-gene classifier and a biomarker (called \u201cCORE-37\u201d) are developed to predict the molecular subtype of CCA and prognosis, respectively. Two subtypes display distinct molecular characteristics and survival outcomes. Key findings are validated in external cohorts regardless of the stage and anatomical location. Our study provides a CCA classification scheme that complements the conventional anatomy-based classification and presents a promising prognostic biomarker for clinical application.<\/jats:p>","DOI":"10.1038\/s41467-024-44748-8","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T19:02:55Z","timestamp":1704999775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["A transcriptome based molecular classification scheme for cholangiocarcinoma and subtype-derived prognostic biomarker"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhongqi","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0654-0377","authenticated-orcid":false,"given":"Xinchen","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2478-1521","authenticated-orcid":false,"given":"Yanfang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0945-1568","authenticated-orcid":false,"given":"Haoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiwen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijiao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4656-4955","authenticated-orcid":false,"given":"Guoyue","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"44748_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","volume":"13","author":"JM Banales","year":"2016","unstructured":"Banales, J. M. et al. Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA). Nat. Rev. Gastroenterol. Hepatol. 13, 261\u2013280 (2016).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"44748_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","volume":"71","author":"P Bertuccio","year":"2019","unstructured":"Bertuccio, P. et al. Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma. J. Hepatol. 71, 104\u2013114 (2019).","journal-title":"J. Hepatol."},{"key":"44748_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales, J. M. et al. Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat. Rev. Gastroenterol. Hepatol. 17, 557\u2013588 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"44748_CR4","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","volume":"8","author":"B Blechacz","year":"2011","unstructured":"Blechacz, B., Komuta, M., Roskams, T. & Gores, G. J. Clinical diagnosis and staging of cholangiocarcinoma. Nat. Rev. Gastroenterol. Hepatol. 8, 512\u2013522 (2011).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"44748_CR5","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/liv.14093","volume":"39 (Suppl. 1)","author":"T Kendall","year":"2019","unstructured":"Kendall, T. et al. Anatomical, histomorphological and molecular classification of cholangiocarcinoma. Liver Int. 39 (Suppl. 1), 7\u201318 (2019).","journal-title":"Liver Int."},{"key":"44748_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93250-4","volume":"11","author":"H Li","year":"2021","unstructured":"Li, H. et al. A comprehensive transcriptomic landscape of cholangiocarcinoma based on bioinformatics analysis from large cohort of patients. Sci. Rep. 11, 13713 (2021).","journal-title":"Sci. Rep."},{"key":"44748_CR7","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1158\/2159-8290.CD-20-0766","volume":"11","author":"IM Silverman","year":"2021","unstructured":"Silverman, I. M. et al. Clinicogenomic Analysis of FGFR2-Rearranged Cholangiocarcinoma Identifies Correlates of Response and Mechanisms of Resistance to Pemigatinib. Cancer Discov. 11, 326\u2013339 (2021).","journal-title":"Cancer Discov."},{"key":"44748_CR8","doi-asserted-by":"publisher","first-page":"e0231877","DOI":"10.1371\/journal.pone.0231877","volume":"15","author":"PCC Liu","year":"2020","unstructured":"Liu, P. C. C. et al. INCB054828 (pemigatinib), a potent and selective inhibitor of fibroblast growth factor receptors 1, 2, and 3, displays activity against genetically defined tumor models. PLoS ONE 15, e0231877 (2020).","journal-title":"PLoS ONE"},{"key":"44748_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jhep.2020.03.008","volume":"73","author":"R Montal","year":"2020","unstructured":"Montal, R. et al. Molecular classification and therapeutic targets in extrahepatic cholangiocarcinoma. J, Hepatol. 73, 315\u2013327 (2020).","journal-title":"J, Hepatol."},{"key":"44748_CR10","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1053\/j.gastro.2013.01.001","volume":"144","author":"D Sia","year":"2013","unstructured":"Sia, D. et al. Integrative molecular analysis of intrahepatic cholangiocarcinoma reveals 2 classes that have different outcomes. Gastroenterology 144, 829\u2013840 (2013).","journal-title":"Gastroenterology"},{"key":"44748_CR11","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1053\/j.gastro.2011.12.005","volume":"142","author":"JB Andersen","year":"2012","unstructured":"Andersen, J. B. et al. Genomic and genetic characterization of cholangiocarcinoma identifies therapeutic targets for tyrosine kinase inhibitors. Gastroenterology 142, 1021\u20131031.e15 (2012).","journal-title":"Gastroenterology"},{"key":"44748_CR12","doi-asserted-by":"publisher","first-page":"D1031","DOI":"10.1093\/nar\/gkx850","volume":"46","author":"P Kim","year":"2018","unstructured":"Kim, P. et al. TissGDB: tissue-specific gene database in cancer. Nucleic Acids Res. 46, D1031\u2013D1038 (2018).","journal-title":"Nucleic Acids Res."},{"key":"44748_CR13","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1038\/nm0603-677","volume":"9","author":"CW Pugh","year":"2003","unstructured":"Pugh, C. W. & Ratcliffe, P. J. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat. Med. 9, 677\u2013684 (2003).","journal-title":"Nat. Med."},{"key":"44748_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1124\/mi.11.1.4","volume":"11","author":"PA Johnston","year":"2011","unstructured":"Johnston, P. A. & Grandis, J. R. STAT3 signaling: anticancer strategies and challenges. Mol. Interv. 11, 18\u201326 (2011).","journal-title":"Mol. Interv."},{"key":"44748_CR15","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13045-017-0471-6","volume":"10","author":"SG Pai","year":"2017","unstructured":"Pai, S. G. et al. Wnt\/beta-catenin pathway: modulating anticancer immune response. J. Hematol. Oncol. 10, 101 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"44748_CR16","doi-asserted-by":"publisher","first-page":"e000003","DOI":"10.1136\/egastro-2023-000003","volume":"1","author":"A Guillot","year":"2023","unstructured":"Guillot, A. & Tacke, F. Spatial dimension of macrophage heterogeneity in liver diseases. eGastroenterology 1, e000003 (2023).","journal-title":"eGastroenterology"},{"key":"44748_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.bbcan.2018.12.002","volume":"1871","author":"M Wang","year":"2019","unstructured":"Wang, M., Liu, Y., Cheng, Y., Wei, Y. & Wei, X. Immune checkpoint blockade and its combination therapy with small-molecule inhibitors for cancer treatment. Biochim. Biophys. Acta Rev. Cancer 1871, 199\u2013224 (2019).","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"44748_CR18","doi-asserted-by":"publisher","first-page":"6997","DOI":"10.1158\/0008-5472.CAN-11-1466","volume":"71","author":"M Hong","year":"2011","unstructured":"Hong, M. et al. Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control. Cancer Res. 71, 6997\u20137009 (2011).","journal-title":"Cancer Res."},{"key":"44748_CR19","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/jid.2011.128","volume":"131","author":"A Nardin","year":"2011","unstructured":"Nardin, A. et al. Dacarbazine promotes stromal remodeling and lymphocyte infiltration in cutaneous melanoma lesions. J. Invest. Dermatol. 131, 1896\u20131905 (2011).","journal-title":"J. Invest. Dermatol."},{"key":"44748_CR20","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1080\/21645515.2020.1840254","volume":"17","author":"C Chen","year":"2021","unstructured":"Chen, C., Liu, Y. & Cui, B. Effect of radiotherapy on T cell and PD-1 \/ PD-L1 blocking therapy in tumor microenvironment. Hum. Vaccin. Immunother. 17, 1555\u20131567 (2021).","journal-title":"Hum. Vaccin. Immunother."},{"key":"44748_CR21","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nrc3214","volume":"12","author":"JM Peters","year":"2012","unstructured":"Peters, J. M., Shah, Y. M. & Gonzalez, F. J. The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. Nat. Rev. Cancer 12, 181\u2013195 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"44748_CR22","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi, J., Zhu, J., Wu, J., Thompson, C. B. & Jiang, X. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc. Natl Acad. Sci. USA 117, 31189\u201331197 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"44748_CR23","doi-asserted-by":"publisher","first-page":"619242","DOI":"10.3389\/fonc.2021.619242","volume":"11","author":"Z Liu","year":"2021","unstructured":"Liu, Z. et al. The identification and validation of two heterogenous subtypes and a risk signature based on ferroptosis in hepatocellular carcinoma. Front. Oncol. 11, 619242 (2021).","journal-title":"Front. Oncol."},{"key":"44748_CR24","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.3390\/ijms23031659","volume":"23","author":"YH Lin","year":"2022","unstructured":"Lin, Y. H. et al. Functional role of mitochondrial DNA in cancer progression. Int. J. Mol. Sci. 23, 1659 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"44748_CR25","doi-asserted-by":"publisher","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","volume":"18","author":"F Farshidfar","year":"2017","unstructured":"Farshidfar, F. et al. Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles. Cell Rep. 18, 2780\u20132794 (2017).","journal-title":"Cell Rep."},{"key":"44748_CR26","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2021.12.006","volume":"40","author":"L Dong","year":"2022","unstructured":"Dong, L. et al. Proteogenomic characterization identifies clinically relevant subgroups of intrahepatic cholangiocarcinoma. Cancer Cell 40, 70\u201387.e15 (2022).","journal-title":"Cancer Cell"},{"key":"44748_CR27","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","volume":"7","author":"A Jusakul","year":"2017","unstructured":"Jusakul, A. et al. Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma. Cancer Discov. 7, 1116\u20131135 (2017).","journal-title":"Cancer Discov."},{"key":"44748_CR28","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.gendis.2020.11.019","volume":"9","author":"F Pu","year":"2020","unstructured":"Pu, F. et al. Ferroptosis as a novel form of regulated cell death: implications in the pathogenesis, oncometabolism and treatment of human cancer. Genes Dis. 9, 347\u2013357 (2020).","journal-title":"Genes Dis."},{"key":"44748_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"44748_CR30","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/nbt.3122","volume":"33","author":"M Pertea","year":"2015","unstructured":"Pertea, M. et al. StringTie enables improved reconstruction of a transcriptome from RNA-seq reads. Nat. Biotechnol. 33, 290\u2013295 (2015).","journal-title":"Nat. Biotechnol."},{"key":"44748_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1910-1","volume":"20","author":"S Kovaka","year":"2019","unstructured":"Kovaka, S. et al. Transcriptome assembly from long-read RNA-seq alignments with StringTie2. Genome Biol. 20, 278 (2019).","journal-title":"Genome Biol."},{"key":"44748_CR32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-16747-x","volume":"7","author":"PW Eide","year":"2017","unstructured":"Eide, P. W., Bruun, J., Lothe, R. A. & Sveen, A. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models. Sci. Rep. 7, 16618 (2017).","journal-title":"Sci. Rep."},{"key":"44748_CR33","doi-asserted-by":"publisher","first-page":"e15543","DOI":"10.1371\/journal.pone.0015543","volume":"5","author":"Y Hoshida","year":"2010","unstructured":"Hoshida, Y. Nearest template prediction: a single-sample-based flexible class prediction with confidence assessment. PLoS ONE 5, e15543 (2010).","journal-title":"PLoS ONE"},{"key":"44748_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-11-367","volume":"11","author":"R Gaujoux","year":"2010","unstructured":"Gaujoux, R. & Seoighe, C. A flexible R package for nonnegative matrix factorization. BMC Bioinformatics 11, 367 (2010).","journal-title":"BMC Bioinformatics"},{"key":"44748_CR35","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson, M. D. & Hayes, D. N. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics 26, 1572\u20131573 (2010).","journal-title":"Bioinformatics"},{"key":"44748_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics 14, 7 (2013).","journal-title":"BMC Bioinformatics"},{"key":"44748_CR37","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 1, 417\u2013425 (2015).","journal-title":"Cell Syst."},{"key":"44748_CR38","doi-asserted-by":"publisher","first-page":"4879","DOI":"10.1158\/1078-0432.CCR-13-0542","volume":"19","author":"A Eustace","year":"2013","unstructured":"Eustace, A. et al. A 26-gene hypoxia signature predicts benefit from hypoxia-modifying therapy in laryngeal cancer but not bladder cancer. Clin. Cancer Res. 19, 4879\u20134888 (2013).","journal-title":"Clin. Cancer Res."},{"key":"44748_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara, K. et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat. Commun. 4, 2612 (2013).","journal-title":"Nat. Commun."},{"key":"44748_CR40","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","volume":"37","author":"AM Newman","year":"2019","unstructured":"Newman, A. M. et al. Determining cell type abundance and expression from bulk tissues with digital cytometry. Nat. Biotechnol. 37, 773\u2013782 (2019).","journal-title":"Nat. Biotechnol."},{"key":"44748_CR41","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"key":"44748_CR42","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng0506-500","volume":"38","author":"M Reich","year":"2006","unstructured":"Reich, M. et al. GenePattern 2.0. Nat. Genet. 38, 500\u2013501 (2006).","journal-title":"Nat. Genet."},{"key":"44748_CR43","doi-asserted-by":"publisher","unstructured":"Kampf C., Olsson I., Ryberg U., Sj\u00f6stedt E., Pont\u00e9n F. Production of tissue microarrays, immunohistochemistry staining and digitalization within the human protein atlas. J. Vis. Exp. https:\/\/doi.org\/10.3791\/3620 (2012).","DOI":"10.3791\/3620"},{"key":"44748_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"44748_CR45","doi-asserted-by":"publisher","DOI":"10.1186\/s12859-018-2435-4","volume":"19","author":"M Foroutan","year":"2018","unstructured":"Foroutan, M. et al. Single sample scoring of molecular phenotypes. BMC Bioinformatics 19, 404 (2018).","journal-title":"BMC Bioinformatics"},{"key":"44748_CR46","doi-asserted-by":"publisher","first-page":"e113","DOI":"10.1093\/nar\/gkaa802","volume":"48","author":"DD Bhuva","year":"2020","unstructured":"Bhuva, D. D., Cursons, J. & Davis, M. J. Stable gene expression for normalisation and single-sample scoring. Nucleic Acids Res. 48, e113 (2020).","journal-title":"Nucleic Acids Res."},{"key":"44748_CR47","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.gpb.2021.08.001","volume":"19","author":"T Chen","year":"2021","unstructured":"Chen, T. et al. The genome sequence archive family: toward explosive data growth and diverse data types. Genom. Proteom. Bioinform. 19, 578\u2013583 (2021).","journal-title":"Genom. Proteom. Bioinform."},{"key":"44748_CR48","doi-asserted-by":"publisher","first-page":"D18","DOI":"10.1093\/nar\/gkac1073","volume":"51","author":"CNCB-NGDC Members and Partners.","year":"2023","unstructured":"CNCB-NGDC Members and Partners. Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2023. Nucleic Acids Res. 51, D18\u2013D28 (2023).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44748-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44748-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44748-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T19:03:10Z","timestamp":1704999790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-024-44748-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["44748"],"URL":"https:\/\/doi.org\/10.1038\/s41467-024-44748-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]},"assertion":[{"value":"1 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"484"}}